Skip to main content
. 2016 Aug 25;6:32020. doi: 10.1038/srep32020

Figure 3. Forest plot of overall survival in advanced NSCLC patients who received immune checkpoint inhibitors with or without chemotherapy compared to control therapies.

Figure 3

I: immunotherapy; C: chemotherapy; P: placebo.